The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Toxicity in patients (pts) age 65 or older with dose-adjusted REPOCH (DA-REPOCH) for untreated diffuse large B-cell lymphoma (DLBCL).
Deborah Marie Stephens
No relevant relationships to disclose
Amy S. Ruppert
No relevant relationships to disclose
Beth Christian
No relevant relationships to disclose
Jeffrey Alan Jones
No relevant relationships to disclose
Joseph M. Flynn
No relevant relationships to disclose
Pierluigi Porcu
No relevant relationships to disclose
Robert A. Baiocchi
No relevant relationships to disclose
John C. Byrd
No relevant relationships to disclose
Emily K. Dotson
No relevant relationships to disclose
Brooke S. Crawford
No relevant relationships to disclose
Kristie A. Blum
No relevant relationships to disclose